Literature DB >> 16179262

Increased extracellular glutamate evoked by 1-methyl-4-phenylpyridinium [MPP(+)] in the rat striatum is not essential for dopaminergic neurotoxicity and is not derived from released glutathione.

S B Foster1, H Tang, K E Miller, G Dryhurst.   

Abstract

A number of studies have implicated the interactions of the excitatory amino acid L-glutamate (Glu) with its ionotropic and metabotropic receptors as important components of the mechanism underlying the dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium [MPP(+)]. Furthermore, microdialysis experiments have demonstrated that perfusion of relatively high concentrations of MPP(+) into the rat striatum evoke a delayed, massive release of Glu. Interestingly, perfusion of MPP(+) also mediates a similar release of glutathione (GSH). Together, these observations raise the possibility that the rise of extracellular Glu mediated by MPP(+) may be the result of hydrolysis of released GSH by gamma-glutamyl transpeptidase (gamma-GT). In the present investigation it is demonstrated that perfusions of solutions of 0.7 and 1.3 mM MPP(+) dissolved in artificial cerebrospinal fluid into the rat striatum evoke neurotoxic damage to dopaminergic terminals, assessed by both a two-day test/challenge procedure and tyrosine hydroxylase immunoreactivity, but without the release of Glu. Perfusions of 2.5 mM MPP(+) cause more extensive dopaminergic neurotoxicity and a dose-dependent release of Glu. However, neither this release of Glu nor MPP(+)-induced dopaminergic neurotoxicity are blocked by the irreversible gamma-GT inhibitor acivicin. Together, these observations indicate that a rise of extracellular levels of Glu is not essential for the dopaminergic neurotoxicity of MPP(+). Furthermore, the rise of extracellular Glu caused by perfusion of 2.5 mM MPP(+) is not the result of the gamma-GT-mediated hydrolysis of released GSH. It is possible that the rise of extracellular levels of Glu, L-aspartate, L-glycine and L-taurine evoked by perfusions of 2.5 mM MPP(+) into the rat striatum may reflect, at least in part, the release of these amino acids from astrocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179262     DOI: 10.1007/bf03033883

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  64 in total

Review 1.  Glial cell response: A pathogenic factor in Parkinson's disease.

Authors:  Du Chu Wu; Kim Tieu; Oren Cohen; Dong-Kug Choi; Miquel Vila; Vernice Jackson-Lewis; Peter Teismann; Serge Przedborski
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

2.  Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease.

Authors:  T Klockgether; L Turski
Journal:  Trends Neurosci       Date:  1989-08       Impact factor: 13.837

3.  Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.

Authors:  S Przedborski; Q Chen; M Vila; B I Giasson; R Djaldatti; S Vukosavic; J M Souza; V Jackson-Lewis; V M Lee; H Ischiropoulos
Journal:  J Neurochem       Date:  2001-01       Impact factor: 5.372

4.  Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain.

Authors:  P Chan; L E DeLanney; I Irwin; J W Langston; D Di Monte
Journal:  J Neurochem       Date:  1991-07       Impact factor: 5.372

5.  Aminopeptidase N mediates the utilization of the GSH precursor CysGly by cultured neurons.

Authors:  R Dringen; J M Gutterer; C Gros; J Hirrlinger
Journal:  J Neurosci Res       Date:  2001-12-01       Impact factor: 4.164

Review 6.  Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism.

Authors:  P K Sonsalla; D S Albers; G D Zeevalk
Journal:  Amino Acids       Date:  1998       Impact factor: 3.520

Review 7.  Arachidonic acid as a neurotoxic and neurotrophic substance.

Authors:  H Katsuki; S Okuda
Journal:  Prog Neurobiol       Date:  1995-08       Impact factor: 11.685

8.  Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism.

Authors:  A S Mandir; S Przedborski; V Jackson-Lewis; Z Q Wang; C M Simbulan-Rosenthal; M E Smulson; B E Hoffman; D B Guastella; V L Dawson; T M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

9.  The non-competitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenylpyridinium (MPP+).

Authors:  S Carboni; F Melis; L Pani; M Hadjiconstantinou; Z L Rossetti
Journal:  Neurosci Lett       Date:  1990-09-04       Impact factor: 3.046

10.  Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+.

Authors:  B R Ransom; D M Kunis; I Irwin; J W Langston
Journal:  Neurosci Lett       Date:  1987-04-10       Impact factor: 3.046

View more
  1 in total

Review 1.  Neurotoxins and neurotoxicity mechanisms. An overview.

Authors:  Juan Segura-Aguilar; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.